20th Nov 2008 16:04
Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 20 November 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, on 19 November 2008, the following notification of interest in the ordinary share capital of the Company was received from Aviva plc.
1. Reason for the notification (please tick the appropriate box or boxes) |
||
A disposal voting rights |
X |
|
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
||
An event changing the breakdown of voting rights |
||
Other (please specify): |
||
2. Full name of person(s) subject to the notification obligation: |
Aviva plc & its subsidiaries |
|
3. Full name of shareholder(s) (if different from 2.): |
Registered Holder: BNY Norwich Union Nominees Limited 5,959,368* Chase GA Group Nominees Limited 19,321,240* Chase Nominees Limited879,543* CUIM Nominee Limited4,366,418* Vidacos Nominees Limited65,125* *denotes direct interest
BNP Paribas - London636,429 Chase Nominees Limited 3,065,451 State Street Nominees Limited 9,428,137 Vidacos Nominees Limited 1,603,080 |
|
4. Date of the transaction (and date on which the threshold is crossed or reached if different): |
18 November 2008 |
|
5. Date on which issuer notified: |
19 November 2008 |
|
6. Threshold(s) that is/are crossed or reached: |
13% to 12% Change at Combined Interest level |
|
7. Notified details: |
A: Voting rights attached to shares |
|||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the Triggering transaction |
Resulting situation after the triggering transaction |
|||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
Ordinary Shares GB0007029209 |
45,971,166 |
45,971,166 |
30,591,694 |
30,591,694 |
14,733,097 |
8.73% |
4.20% |
B: Financial Instruments |
||||
Resulting situation after the triggering transaction |
||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
N/A |
||||
Total (A+B) |
|
Number of voting rights |
% of voting rights |
45,324,791 |
12.93% |
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable : |
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: Aviva plc (Parent Company) Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) |
Proxy Voting: |
|
9. Name of the proxy holder: |
See Section 3 |
10. Number of voting rights proxy holder will cease to hold: |
|
11. Date on which proxy holder will cease to hold voting rights: |
|
12. Additional information: |
Figures are based on a revised total number of voting rights of 350,427,481 |
| Ends |
For further information please contact:
Protherics |
|
Nick Staples, Director of Corporate Affairs |
+44 (0) 7919 480510 |
Julie Vickers, Company Secretary |
+44 (0)1928 518010 |
Financial Dynamics - press enquiries |
|
London: Ben Atwell, Lara Mott |
+44 (0) 20 7831 3113 |
New York: John Capodanno |
+1 212 850 5600 |
Or visit www.protherics.com
Related Shares:
Aviva